Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zentalis Pharmaceuticals (ZNTL) Return on Assets (2022 - 2025)

Historic Return on Assets for Zentalis Pharmaceuticals (ZNTL) over the last 4 years, with Q3 2025 value amounting to 0.44%.

  • Zentalis Pharmaceuticals' Return on Assets fell 600.0% to 0.44% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.44%, marking a year-over-year decrease of 600.0%. This contributed to the annual value of 0.34% for FY2024, which is 1700.0% up from last year.
  • Zentalis Pharmaceuticals' Return on Assets amounted to 0.44% in Q3 2025, which was down 600.0% from 0.44% recorded in Q2 2025.
  • Zentalis Pharmaceuticals' 5-year Return on Assets high stood at 0.37% for Q1 2024, and its period low was 0.55% during Q1 2025.
  • In the last 4 years, Zentalis Pharmaceuticals' Return on Assets had a median value of 0.44% in 2023 and averaged 0.43%.
  • Per our database at Business Quant, Zentalis Pharmaceuticals' Return on Assets surged by 1100bps in 2024 and then plummeted by -1800bps in 2025.
  • Zentalis Pharmaceuticals' Return on Assets (Quarter) stood at 0.41% in 2022, then dropped by -18bps to 0.49% in 2023, then rose by 22bps to 0.38% in 2024, then decreased by -17bps to 0.44% in 2025.
  • Its last three reported values are 0.44% in Q3 2025, 0.44% for Q2 2025, and 0.55% during Q1 2025.